GARDskin approved by OECD
THE FIRST AND ONLY Genomics and Machine-learning based in vitro skin sensitization assay
The GARD® technology: An holistic approach
SenzaGen provides state-of-the-art non-animal tests for assessing a substance’s allergenicity. With excellent predictivity, the tests meet needs in several industries and help companies develop, produce and deliver safer, ethical and more sustainable products.
Press Releases
12 May, 2026
News
IR
English
Regulatory
MAR
Report
Interim
Q1
05 May, 2026
News
IR
English
Corporate Information
Other Corporate Information
mfn-ext-nq
mfn-ext-nq-company-announcement
21 Apr, 2026
News
IR
English
Regulatory
Listing Regulation
Report
Annual
News Posts
Quick Links
Contact
Privacy Policy (En)
Privacy Policy (Sv)
General Terms and Conditions
© SenzaGen 2026





